EZH2 and osteosarcoma: In osteosarcoma specifically, EZH2 activity is frequently elevated and mechanistically connected to undifferentiated programs; although the immunologic consequences have not been fully mapped in patient material, these observations align with a model in which PRC2 activity imposes a reversible ceiling on antigen presentation capacity in subsets of tumors.